NO901213L - Genetiske enheter for inhibering av rna-funksjonen. - Google Patents

Genetiske enheter for inhibering av rna-funksjonen.

Info

Publication number
NO901213L
NO901213L NO90901213A NO901213A NO901213L NO 901213 L NO901213 L NO 901213L NO 90901213 A NO90901213 A NO 90901213A NO 901213 A NO901213 A NO 901213A NO 901213 L NO901213 L NO 901213L
Authority
NO
Norway
Prior art keywords
units
rna
inhibiting
genetic
unit
Prior art date
Application number
NO90901213A
Other languages
English (en)
Other versions
NO901213D0 (no
NO306623B1 (no
Inventor
Hartmut Beug
Max L Birnstiel
Matthew Cotten
Ernst Wagner
Harald Kandolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO901213D0 publication Critical patent/NO901213D0/no
Publication of NO901213L publication Critical patent/NO901213L/no
Publication of NO306623B1 publication Critical patent/NO306623B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO901213A 1989-03-16 1990-03-15 Fremgangsmåte for fremstilling av DNA-molekyl inneholdende deler av et gen som transkriberes av polymerase III og en DNA-sekvens som koder for et inhiberende RNA-molekyl NO306623B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (3)

Publication Number Publication Date
NO901213D0 NO901213D0 (no) 1990-03-15
NO901213L true NO901213L (no) 1990-09-17
NO306623B1 NO306623B1 (no) 1999-11-29

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901213A NO306623B1 (no) 1989-03-16 1990-03-15 Fremgangsmåte for fremstilling av DNA-molekyl inneholdende deler av et gen som transkriberes av polymerase III og en DNA-sekvens som koder for et inhiberende RNA-molekyl

Country Status (20)

Country Link
EP (1) EP0387775B1 (no)
JP (1) JP3330930B2 (no)
KR (1) KR900014591A (no)
AT (1) ATE140961T1 (no)
AU (1) AU637354B2 (no)
CA (1) CA2012312C (no)
DD (1) DD297838A5 (no)
DE (1) DE59010432D1 (no)
DK (1) DK0387775T3 (no)
ES (1) ES2090049T3 (no)
FI (1) FI105103B (no)
GR (1) GR3020935T3 (no)
HU (2) HU215187B (no)
IE (1) IE74850B1 (no)
IL (1) IL93754A (no)
NO (1) NO306623B1 (no)
NZ (1) NZ232917A (no)
PT (1) PT93440B (no)
RU (1) RU2136751C1 (no)
ZA (1) ZA901973B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE4091533T (no) * 1989-08-31 1992-01-30
JP2507895B2 (ja) * 1989-12-19 1996-06-19 工業技術院長 リボザイムの新規合成系
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
WO1991019789A1 (en) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases
DE69123979T2 (de) 1990-10-12 1997-04-30 Max Planck Gesellschaft Abgeänderte ribozyme
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.
AU4259193A (en) * 1992-04-28 1993-11-29 Frank Andreas Harald Meyer Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
JPH08502950A (ja) * 1992-05-14 1996-04-02 リボザイム・ファーマシューティカルズ・インコーポレイテッド 癌増殖を抑制する方法及び試薬
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
CA2114312A1 (en) * 1992-05-27 1993-12-09 John J. Rossi Chimeric trnalys-ribozyme molecules
RU94046396A (ru) * 1992-06-29 1996-11-10 Джин Ширс Пти.Лтд. (AU) Нуклеиновая кислота, днк, вектор, способ получения растения или животного, способ получения клеток, способ создания животного, животное, трансгенное животное, трансгенное растение, плоды, черенки и семена, растительные клетки, способ вмешательства в репликацию вируса
AU5968994A (en) * 1992-12-16 1994-07-04 Johanna E. Bergmann Agents for the prevention and treatment of human alzheimer's disease
DE69333216T2 (de) * 1993-07-06 2004-06-24 Université de Nice-Sophia Antipolis Vektor, enthält ein bei ARN-Polymerase-III transcriptes Virus-Gen
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
WO1995019788A1 (en) * 1994-01-24 1995-07-27 City Of Hope Inhibitors and target molecule co-localization
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
NZ308970A (en) 1995-06-07 1999-10-28 Commw Scient Ind Res Org Optimized minizymes and miniribozymes and uses thereof
FR2755976B1 (fr) * 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6057156A (en) 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
AU1187099A (en) * 1997-10-21 1999-05-10 Ribozyme Pharmaceuticals, Inc. Peptide bond formation using nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP1857549B1 (en) 1998-03-20 2018-10-17 Commonwealth Scientific and Industrial Research Organisation Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (en) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
IL93754A0 (en) 1990-12-23
EP0387775A1 (de) 1990-09-19
IE900931L (en) 1990-09-16
NZ232917A (en) 1997-07-27
FI105103B (fi) 2000-06-15
HUT54206A (en) 1991-01-28
DK0387775T3 (da) 1996-11-04
CA2012312A1 (en) 1990-09-16
NO901213D0 (no) 1990-03-15
KR900014591A (ko) 1990-10-24
ATE140961T1 (de) 1996-08-15
JPH03130080A (ja) 1991-06-03
JP3330930B2 (ja) 2002-10-07
AU637354B2 (en) 1993-05-27
AU5130190A (en) 1990-11-01
CA2012312C (en) 2001-08-14
IE74850B1 (en) 1997-08-13
RU2136751C1 (ru) 1999-09-10
GR3020935T3 (en) 1996-12-31
DD297838A5 (de) 1992-01-23
ES2090049T3 (es) 1996-10-16
HU211868A9 (en) 1995-12-28
EP0387775B1 (de) 1996-07-31
HU901584D0 (en) 1990-06-28
HU215187B (hu) 1998-10-28
ZA901973B (en) 1991-11-27
IL93754A (en) 1995-12-31
DE59010432D1 (de) 1996-09-05
PT93440A (pt) 1990-11-07
NO306623B1 (no) 1999-11-29
FI901296A0 (fi) 1990-03-15
PT93440B (pt) 2001-07-31

Similar Documents

Publication Publication Date Title
NO901213L (no) Genetiske enheter for inhibering av rna-funksjonen.
WO1996019568A3 (en) Stabilized ribozyme analogs
AU4072089A (en) Inhibition of htlv-iii by exogenous oligonucleotides
ATE189264T1 (de) Chimärisches oligonukleotid und dessen verwendung zur herstellung von nukleinsäure-transkripten
ES2180622T3 (es) Oligonucleotidos antisentido con actividad inhibidora de tumorigenicidad.
EP0572287A3 (en) Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
EP0637316A4 (en) ANTISENSE OLIGONUCLEOTIDE INHIBITORS OF PAPILLOMAVIRUS.
DE69331946T2 (de) Nukleozyme
EP0708829B8 (en) A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
HUP0103465A2 (hu) A VEGF expressziójának gátlására szolgáló rövid oligonukleotidok
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
Nakashima et al. Proximity of mRNA5′-region and 18S rRNA in eukaryotic initiation complexes
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
DE69921609D1 (de) Ribozymale nukleinsäure die ccr5 oder cxcr4 schneiden
AU6144294A (en) Plant virus resistance conferring polyribozyme and resistant plants producing same
Richardson et al. Identification of upstream sequence components of rho-dependent transcription terminators.
AU3956100A (en) Rna polymerase i transcription factor tif-ia
CA2103062A1 (en) Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity

Legal Events

Date Code Title Description
MK1K Patent expired